(DOCS) Doximity - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US26622P1075
DOCS: Cloud, Platform, Tools, Software, Network, Healthcare, Technology
Doximity, Inc. (NYSE:DOCS) is a cloud-based digital platform designed specifically for medical professionals in the United States. It serves as a professional network akin to LinkedIn but tailored for doctors, offering a suite of tools that enhance collaboration, knowledge sharing, and practice management. The platforms features include secure messaging, a medical newsfeed, career management tools, and telemedicine capabilities, making it an essential resource for physicians, nurse practitioners, and healthcare organizations.
The companys strategic advantage lies in its network effects. As more medical professionals join, the platform becomes increasingly valuable, creating a virtuous cycle that solidifies its position in the market. This specialization allows Doximity to address unique challenges in healthcare communication and collaboration more effectively than general-purpose platforms.
Doximitys financial profile reflects its growth trajectory. With a market capitalization exceeding $14 billion, it is a significant player in the health technology sector. The trailing P/E ratio of approximately 77 and a forward P/E of 52 suggest that investors anticipate substantial future growth. The price-to-sales ratio of nearly 28 indicates a premium valuation, typical of high-growth tech companies.
For investors, Doximity represents a compelling opportunity in the healthcare technology space, particularly as digital transformation continues to reshape the industry. Its focus on serving medical professionals positions it well to capitalize on the growing need for efficient, secure, and specialized digital solutions in healthcare.
Additional Sources for DOCS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DOCS Stock Overview
Market Cap in USD | 12,377m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2021-06-24 |
DOCS Stock Ratings
Growth 5y | 17.0% |
Fundamental | 55.7% |
Dividend | 0.0% |
Rel. Strength Industry | 126 |
Analysts | 3.53/5 |
Fair Price Momentum | 64.14 USD |
Fair Price DCF | 14.35 USD |
DOCS Dividends
No Dividends PaidDOCS Growth Ratios
Growth Correlation 3m | 77.2% |
Growth Correlation 12m | 94.4% |
Growth Correlation 5y | -36% |
CAGR 5y | 4.92% |
CAGR/Max DD 5y | 0.06 |
Sharpe Ratio 12m | 0.52 |
Alpha | 111.14 |
Beta | 1.88 |
Volatility | 63.03% |
Current Volume | 1739.1k |
Average Volume 20d | 2387.9k |
As of March 15, 2025, the stock is trading at USD 63.38 with a total of 1,739,073 shares traded.
Over the past week, the price has changed by -0.94%, over one month by -17.76%, over three months by +18.96% and over the past year by +127.58%.
Partly, yes. Based on ValueRay Fundamental Analyses, Doximity (NYSE:DOCS) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.68 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCS as of March 2025 is 64.14. This means that DOCS is currently overvalued and has a potential downside of 1.2%.
Doximity has received a consensus analysts rating of 3.53. Therefor, it is recommend to hold DOCS.
- Strong Buy: 4
- Buy: 2
- Hold: 13
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DOCS Doximity will be worth about 73.8 in March 2026. The stock is currently trading at 63.38. This means that the stock has a potential upside of +16.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 74.9 | 18.2% |
Analysts Target Price | 55.1 | -13% |
ValueRay Target Price | 73.8 | 16.5% |